Delocamten clinical trials
Also written BMS-986435 and MYK-224.
How each study uses delocamten is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the delocamten studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
9 studies that test it; most in 2023 (3)
| Year | Studies |
|---|---|
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test delocamten.
- Dec 2026Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)Phase 2 · Bristol-Myers Squibb
- Dec 2026A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult ParticipantsPhase 1 · Bristol-Myers Squibb
Studies
Open first, then newest update. How each study uses delocamten is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult ParticipantsRecruitingPhase 1Bristol-Myers SquibbNCT07226817Written as BMS-986435
- A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic ImpairmentCompletedPhase 1Bristol-Myers SquibbNCT07248839Written as BMS-986435
- Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)Active, not recruitingPhase 2Bristol-Myers SquibbNCT06122779Written as BMS-986435
- A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic CardiomyopathyTerminatedPhase 2Bristol-Myers SquibbNCT05556343Written as MYK-224
- Study to Assess Relative Bioavailability of BMS-986435 Formulations in Healthy Adult ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT06577259Written as BMS-986435
- A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of Single Doses of BMS-986435 (MYK-224) in Healthy Chinese ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT06476821Written as BMS-986435
- A Study to Evaluate the Absorption, Metabolism, and Excretion (ADME) of BMS-986435CompletedPhase 1Bristol-Myers SquibbNCT05686096Written as MYK-224
- A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple Doses in Healthy Adult Japanese ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05405543Written as MYK-224
- A Study to Assess the Drug Interaction Between MYK-224 and Itraconazole and Verapamil in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05304533Written as MYK-224
Codes
What other systems call delocamten · ClinicalTrials.gg INT016848
- UNII (FDA) IE5886BN8TDELOCAMTENConfirmed FDA, Wikidata
- Wikidata Q123907189delocamtenConfirmed FDA, Wikidata
- NCI Thesaurus C211772DelocamtenOne source FDA
- DrugBank DB21711One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | IE5886BN8T | DELOCAMTEN | Confirmed FDA, Wikidata |
| Wikidata | Q123907189 | delocamten | Confirmed FDA, Wikidata |
| NCI Thesaurus | C211772 | Delocamten | One source FDA |
| DrugBank | DB21711 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.